Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Next Previous
Trial Profile

Effect of Mexiletine on Cortical Hyperexcitability in Sporadic Amyotrophic Lateral Sclerosis (SALS)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2018

At a glance

  • Drugs Mexiletine (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Therapeutic Use

    • Most Recent Events

    • 11 May 2017 Planned End Date changed from 1 Dec 2017 to 1 May 2018.
    • 11 May 2017 Planned primary completion date changed from 1 Dec 2017 to 1 May 2018.
    • 08 Dec 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top